Literature DB >> 19011769

Defects of FA/BRCA pathway in lymphoma cell lines.

Hui Xiao1, Ke Jian Zhang2, Bing Xia3.   

Abstract

The aim was to find the possible relationship between defects in the FA/BRCA pathway of genomic maintenance and potential pathogenesis of T and B cell lymphoma. We screened 29 cell lines derived from diverse subtypes of lymphoma for possible FA pathway defects. The results indicated: no defect in FANCD2 ubiquitination, BRCA2 and FANCJ expression; absence of FANCN protein in three cell lines: HT, Sudhl4 and JEKO-1. This absence was correlated with enhanced MMC-induced G2 arrest, growth inhibition and high chromosomal breakage rate in the three cell lines. We only found one substitution in HT and JEKO-1 exon-5a fragment: c.1769C > T, p. A590V. But in another lymphoma cell line Sudhl4 with FANCN absence, we have not found any mutation. In conclusion, this mutation maybe the reason which caused FANCN protein expression absent or made the protein very unstable and lose its function in HT and JEKO-1 cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19011769     DOI: 10.1007/s12185-008-0199-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  27 in total

1.  Fanconi anemia gene mutations in young-onset pancreatic cancer.

Authors:  Michiel S van der Heijden; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

Review 2.  The Fanconi anemia pathway limits the severity of mutagenesis.

Authors:  John M Hinz; Peter B Nham; Edmund P Salazar; Larry H Thompson
Journal:  DNA Repair (Amst)       Date:  2006-07-11

3.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

4.  Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.

Authors:  Fergus J Couch; Michele R Johnson; Kari Rabe; Lisa Boardman; Robert McWilliams; Mariza de Andrade; Gloria Petersen
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

5.  Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.

Authors:  Toshiyasu Taniguchi; Marc Tischkowitz; Najim Ameziane; Shirley V Hodgson; Christopher G Mathew; Hans Joenje; Samuel C Mok; Alan D D'Andrea
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

6.  Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.

Authors:  Gopeshwar Narayan; Hugo Arias-Pulido; Subhadra V Nandula; Katia Basso; Dorcas D Sugirtharaj; Hernan Vargas; Mahesh Mansukhani; Jeannine Villella; Larissa Meyer; Achim Schneider; Lutz Gissmann; Matthias Dürst; Bhavana Pothuri; Vundavalli V V S Murty
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 7.  Hallmarks of 'BRCAness' in sporadic cancers.

Authors:  Nicholas Turner; Andrew Tutt; Alan Ashworth
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

8.  Analysis of PALB2/FANCN-associated breast cancer families.

Authors:  Marc Tischkowitz; Bing Xia; Nelly Sabbaghian; Jorge S Reis-Filho; Nancy Hamel; Guilan Li; Erik H van Beers; Lili Li; Tayma Khalil; Louise A Quenneville; Atilla Omeroglu; Aletta Poll; Pierre Lepage; Nora Wong; Petra M Nederlof; Alan Ashworth; Patricia N Tonin; Steven A Narod; David M Livingston; William D Foulkes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

9.  Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.

Authors:  Sanjay Koul; James M McKiernan; Gopeshwar Narayan; Jane Houldsworth; Jennifer Bacik; Deborah L Dobrzynski; Adel M Assaad; Mahesh Mansukhani; Victor E Reuter; George J Bosl; Raju S K Chaganti; Vundavalli V V S Murty
Journal:  Mol Cancer       Date:  2004-05-18       Impact factor: 27.401

10.  CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.

Authors:  Varinderpal S Dhillon; Mohd Shahid; Syed Akhtar Husain
Journal:  Mol Cancer       Date:  2004-12-01       Impact factor: 27.401

View more
  2 in total

1.  Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.

Authors:  Soma Ghosh; Surojit Sur; Sashidhar R Yerram; Carlo Rago; Anil K Bhunia; M Zulfiquer Hossain; Bogdan C Paun; Yunzhao R Ren; Christine A Iacobuzio-Donahue; Nilofer A Azad; Scott E Kern
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

Review 2.  The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.

Authors:  Thales C Nepomuceno; Giuliana De Gregoriis; Francisco M Bastos de Oliveira; Guilherme Suarez-Kurtz; Alvaro N Monteiro; Marcelo A Carvalho
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.